| Date Filed | Type | Description |
| 11/09/2022 |
SC 13D/A
| Niihara Yutaka reports a 26.4% stake in Emmaus Life Sciences, Inc. |
| 02/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/01/2021 |
SC 13D/A
| Niihara Yutaka reports a 26.3% stake in Emmaus Life Sciences, Inc. |
| 07/22/2021 |
SC 13D/A
| Niihara Yutaka reports a 25.8% stake in Emmaus Life Sciences, Inc. |
| 04/02/2020 |
SC 13D/A
| Niihara Yutaka reports a 25.7% stake in Emmaus Life Sciences, Inc. |
| 08/02/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/31/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/14/2019 |
SC 13D/A
| Niihara Yutaka reports a 31.6% stake in Emmaus Life Sciences, Inc. |
| 12/14/2018 |
SC 13D/A
| Niihara Yutaka reports a 31.6% stake in Emmaus Life Sciences, Inc. |
| 11/25/2015 |
SC 13D/A
| Niihara Yutaka reports a 37.5% stake in Emmaus Life Sciences, Inc. |
| 04/27/2015 |
SC 13D/A
| Niihara Yutaka reports a 37.7% stake in Emmaus Life Sciences, Inc. |
| 04/24/2015 |
SC 13D/A
| Niihara Yutaka reports a 37.7% stake in Emmaus Life Sciences, Inc. |
| 04/23/2015 |
SC 13D/A
| Niihara Yutaka reports a 37.7% stake in Emmaus Life Sciences, Inc. |
| 05/06/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |